Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Ardsley Partners and Bioscrip Inc. (BIOS)

Bioscrip Inc. (NASDAQ:BIOS): Philip Hempleman’s Ardsley Partners filed an amended 13D.

You can check out Ardsley Partners’ latest holdings and filings here.

Please follow Ardsley Partners (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Ardsley Partners or update its stock holdings.

Philip Hempleman
Philip Hempleman
Ardsley Partners

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Ardsley Advisory Partners 0 90,000 0 90,000 90,000 0.07%
Philip J. Hempleman 0 90,000 0 90,000 90,000 0.07%
Ardsley Partners I 0 0 0 0 0 0%
Ardsley Partners Fund II 0 0 0 0 0 0%
Ardsley Partners Advanced Healthcare Fund 0 0 0 0 0 0%
Ardsley Duckdive Fund 0 0 0 0 0 0%
Ardsley Healthcare Fund 0 90,000 0 90,000 90,000 0.07%
Philip Hempleman
Philip Hempleman
Ardsley Partners

Page 1 of 13 – SEC Filing


Washington, D.C. 20549


(Amendment No.

the Securities Exchange Act of 1934


(Name of Issuer)


Common Stock

(Title of Class
of Securities)



(CUSIP Number)


31, 2017

(Date of Event
Which Requires Filing of this Statement)


Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:


x Rule
x Rule
o Rule


*The remainder
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior
cover page.


The information
required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).  


who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.

Follow Option Care Health Inc. (NASDAQ:BIOS)
Trade (NASDAQ:BIOS) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.